|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | LY2439821,a humanized anti-interleukin-17 monoclonal antibody,in the treat-ment of patients with rheumatoid arthritis:A phase I randomized,double-blind,placebo-controlled,proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Ar-thritis Rheum2010，62，4： | 1 |
| 2 | LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo- controlled, proof-of-concept study显示文摘 | Genovese MC van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 3 | LY2439821, a humanized anti- interleukin- 17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double- blind, placebo-controlled, proof- of- concept study 显示文摘 | Genovese MC Van den Bosch F Roberson SA et aI | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 4 | A hum- anized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, do- ubleblind, placebo-controlled, proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 5 | LY2439821,a humanized anti-interleukin-17 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:a phase Ⅰ randomized,double-blind,placebo-controlled,proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，64，4： | 1 |
| 6 | LY2439821,a humanized anti-interleukin-17 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:a phase I randomized,double-blind,placebo-controlled,proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，： | 1 |
| 7 | LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo- controlled, proof-of -concept study 显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 8 | LY243-9821,a humanized anti-interleukin-17 monoclonal anti-body,in the treatment of patients with rheumatoid arthritis:a phase Ⅰ randomized,double-blind,placebo-controlled,proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | | 0，，： | 1 |
| 9 | LY2439821, a humanized Anti-Interleukin 17 monoclonal antibody, in the treatment of patients with rheumatoid ar- thritis a phase I randomized, Double-Blind, Placebo- Controlled, Proof-of-Concept study显示文摘 | Genovese MC Van Den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 10 | LY2439821,a humanized anti-IL-17 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:a phase Ⅰ randomized,doubleblind,placebo-controlled,proof-of-concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 11 | LY2439821, a Humanized Anti -Interleukin -17 Monoclonal Antibody, in the Treatment of Patients With Rheumatoid Arthritis A Phase I Randomized,Double-Blind,Placebo- Controlled, Proof -of -Concept Study 显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis and Rheumatism2010，62，4： | 1 |
| 12 | LY2439821, a humanized anti-interleukin- 17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis:A phase I randomized, double-blind,placebo-controlled,proof-o f-concept study显示文摘 | Genovese MC Bosch FV Roberson SA et aI | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 13 | LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis : A phase I randomized, double-blind, placebo-controlled, proof-of- concept study显示文摘 | Genovese MC Van den Bosch F Roberson SA | 2010 | Arthritis Rheum2010，62，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员